about
Phased whole-genome genetic risk in a family quartet using a major allele reference sequenceThe Oslo definitions for coeliac disease and related termsImproving outcomes of refractory celiac disease - current and emerging treatment strategiesThe Spectrum of Differences between Childhood and Adulthood Celiac DiseaseRisk factors for celiac diseaseNew approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunityIs enteroscopy necessary for diagnosis of celiac disease?Immune development and intestinal microbiota in celiac diseaseCoeliac disease and gluten-related disorders in childhoodImproved xenobiotic metabolism and reduced susceptibility to cancer in gluten-sensitive macaques upon introduction of a gluten-free diet.Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection.Clinical practice : coeliac diseaseDQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing AlleleThe management of refractory coeliac disease.The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controlsEpithelial transport of immunogenic and toxic gliadin peptides in vitro.Ineffective degradation of immunogenic gluten epitopes by currently available digestive enzyme supplementsThe Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop.Effects of Gluten Intake on Risk of Celiac Disease: A Case-Control Study on a Swedish Birth Cohort.No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease.DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).Coeliac screening in a Scottish cohort of children with type 1 diabetes mellitus: is DQ typing the way forward?Celiac disease in adult patients: specific autoantibodies in the diagnosis, monitoring, and screening.Novel trends in celiac disease.Shared genetics in coeliac disease and other immune-mediated diseases.New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment.The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet.Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes.HLA and disease: guilt by association.Serological testing for celiac disease in adults.The intestine-renal connection in IgA nephropathy.Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseasesCoeliac disease and rheumatoid arthritis: similar mechanisms, different antigens.Immunopathogenesis and therapeutic approaches in pediatric celiac disease.The gut-kidney axis in IgA nephropathy: role of microbiota and diet on genetic predisposition.Comparison of four functionalization methods of gold nanoparticles for enhancing the enzyme-linked immunosorbent assay (ELISA)Physiopathology and Management of Gluten-Induced Celiac Disease.Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten.Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease.A biased view toward celiac disease.
P2860
Q21144940-A6BB0193-AF62-4380-897C-3D1774764AB0Q24601971-5DABBA82-1EFD-4AF6-BBD8-8B061269473EQ26740769-424B3C5B-6FC8-446D-BE34-0B5B8E0F5101Q26778458-1C10FC50-CA66-4694-9B3F-79D9F6EE1700Q26798375-A8FAADF7-38FD-432D-AEC8-84863E6A0DB7Q26800973-BF942F7D-0A97-4559-91AF-1CC069C0E4C3Q26824813-58BB21BA-4A84-4735-92C1-30DE78A8CF66Q27026098-CCDC9AC4-090B-45D4-AD32-FBE35CCEEC19Q28263872-F344446F-7EFD-484B-95F6-F63CAF96832CQ33886854-C9F12C1F-3A1F-4752-85E3-002A5273C244Q34031257-A04C5FE9-5785-4175-A763-170177BD09EEQ34261754-EC6EE3EF-0FB2-45F0-8F08-54D66138B19FQ34349507-40764E4A-4995-4960-8E1B-B4E11052B030Q34650083-2F68C691-F9BF-46A4-82C5-116D7354C14CQ35268912-EC4A9217-C2FF-4D5E-A952-AA4F17EA2A51Q35442538-6249BDC1-EB3F-4C45-8998-F6840C1AA159Q35647827-D6BE17B0-EA4B-480E-B57A-44100AB94B4DQ35668237-F0BB72C1-263E-40EC-B980-AE51C51E1907Q35802458-17A1E770-6F10-4364-8C3D-9804C3EE5FD0Q35886675-9CE4C625-0E0C-4216-8A35-B6AF328F8044Q35935131-50A376F0-099E-4829-999F-E808DB2471C3Q36681880-D38BB076-A3CE-438C-B521-C686AA2A1D49Q37717826-E6F37485-FF4E-4AD0-AB8D-39A5E31E3454Q37729528-09ED205E-ED7D-4720-8ED3-298B80AE48C4Q37852786-FDCC3C4A-D385-4619-A752-450D7DD86612Q37905046-34C06527-AA9B-492D-ADA0-7AB16191ABB7Q38016781-245CA54B-6C50-4125-8163-FA33B141EA56Q38021639-3A4B2679-4C77-44DE-B441-56849C710EA1Q38134171-984B1134-876D-4477-A2C0-FD4AE6F8FDF1Q38219416-86286285-4E09-4EEF-A31C-AC69B4B67754Q38267177-13EC4BBB-EE71-4F24-A55C-572550830F08Q38291498-EEE75914-760A-491B-BE08-63251489B64BQ38489669-51D5ECF1-83D5-4AC9-A666-B05EC3463AC1Q38783192-186F79B1-4395-4924-9F0E-20915F6AE873Q38847063-A5EDD4BE-49C5-426C-AB46-88930B84D1ABQ38938287-2CAF0BF4-7FCF-40AB-BC8A-6966F405071FQ39111493-A25D68A9-5D2C-4F46-9E5E-5FF644FBAF63Q39325700-234B56B0-060F-4075-B354-CABA7D227A4DQ40254093-BE80B282-5534-4055-9159-4F14DA6EF660Q40743788-8983CACB-51BE-4003-A886-D60F218DE00E
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Celiac disease: how complicated can it get?
@ast
Celiac disease: how complicated can it get?
@en
Celiac disease: how complicated can it get?
@nl
type
label
Celiac disease: how complicated can it get?
@ast
Celiac disease: how complicated can it get?
@en
Celiac disease: how complicated can it get?
@nl
prefLabel
Celiac disease: how complicated can it get?
@ast
Celiac disease: how complicated can it get?
@en
Celiac disease: how complicated can it get?
@nl
P2860
P1433
P1476
Celiac disease: how complicated can it get?
@en
P2093
Frits Koning
Jeroen van Bergen
P2860
P2888
P304
P356
10.1007/S00251-010-0465-9
P407
P577
2010-07-27T00:00:00Z
P5875
P6179
1028328703